ArticleCancer research2010

A therapeutic OX40 agonist dynamically alters dendritic, endothelial, and T cell subsets within the established tumor microenvironment.

Angela D Pardee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.